Christopher Weight, MD, MS, discusses the current state and directions of AI and prostate cancer.
Christopher Weight, MD, MS
Advertisement
Weight is the vice chair over research and the center director for urologic oncology at the Cleveland Clinic in Ohio.
Articles by Christopher Weight, MD, MS
Advertisement
Latest Updated Articles
AI and prostate cancer: Balancing hope and cautionAugust 27th 2025
Advertisement
Advertisement
Trending on Urology Times
1
FDA approves Titan Prime Inflatable Penile Prosthesis
2
Phase 1 AcTION trial establishes RP2D for 225Ac-PSMA-617
3
FDA approves cefepime and zidebactam for complicated UTI
4
FDA updates in urology: May 2026
5